The Top 4 Ways Clinics Can Grow Their Businesses 2023
Wearable Tech News
dorsaVi Technology used in a Scoliosis Research Study
dorsaVi technology used in a Scoliosis Research Article
Interpret and Relay the Results of the AMI to Improve Outcomes
dorsaVi awarded ISO 27001 certification for data security
Half-Year Financial Results 2022
dorsaVi is excited to announce the Athletic Movement Index Blog
dorsaVi advances Medtronic relationship with Master Services Agreement
PRODUCT DEMO – Join us as we discuss how Sensor Technology & Data bring insight and strategies to workplace injury: MARCH 25TH 4:30 PM EDT / 7:30 AM AEDT
dorsaVi partners with WebExercises to deliver brand new product: Movement Solutions
RUNNING WEBINAR PART 1 – How to integrate video gait analysis to your dorsaVi Running assessments
DORSAVI SIGNS AN EVALUATION AGREEMENT WITH MEDTRONIC
dorsaVi partners with Dr. Trent Nessler and NES
dorsaVi signs as a strategic partner of QBE Australia
dorsaVi signs reseller agreement with Therainc Inc
COVID-19 Update
Visit us at CSM
Healthcare Will Drive Wearables
Professional Suite Run FIT Case Study
[LISTEN] dorsaVi Helps Clients Understand How They Move, Which Is Life-Changing
The Role of Movement Analysis in PT and Performance
Professional Suite Competition Winner Announced
[WEBINAR – WATCH NOW] An Introduction to dorsaVi Professional Suite – Low Back
Physiotherapist Advances Wearable Tech Movement With Personal Movement Data
Wareable Tech Awards 2018 Shortlists: dorsaVi Announced as a Finalist
[WEBINAR – WATCH NOW] An Introduction to dorsaVi Professional Suite – Knee
How A Wearable Tech Company Is Enhancing Customer Engagement and Personal Healthcare
How Wearable Technology Is Being Used To Address Injury On and Off the Field
Why Wearable Tech Is Here To Stay
Leveraging Health and Wellness Trends For Medical Grade Impact
Subgroups of lumbo-pelvic flexion kinematics are present in people with and without persistent low back pain
From FitBit to Tech Boom: Why Wearable Technology Is Only Growing
[WEBINAR – WATCH NOW] An Introduction to dorsaVi Professional Suite – Run
dorsaVi signs evaluation agreement with German subsidiary Stryker to assess ViMove2
How To Run Without Pain: 7 Tips To Try
[WEBINAR – WATCH NOW] Announcing The Launch Of dorsaVi Professional Suite
dorsaVi launches Professional Suite for the clinical market in USA
The Best Way To Buy Running Shoes
New York Islanders Using dorsaVi Movement Sensors To Customize Physical Therapy Programs
Preventing ACL Injuries – dorsaVi Technology Featured on Fox 6 News
[REGISTER NOW] Hard Data For Runners (PART 2): Malc Kent’s Approach to Running Analysis and Performance Coaching
dorsaVi at Charm City Run
A new approach to managing pain and medication dependence
Talking Low Back with Duffy & Bracken
First ViMove Mastermind Meeting proves valuable for clinicians
[WEBINAR – WATCH NOW] Hard data for runners: Malc Kent’s approach to running analysis and performance coaching
Wearable sensor technology helps local athletes
Health rehab going high tech (WUSA9)
Business IQ interview with dorsaVi CEO Dr Andrew Ronchi
MedStar Georgetown University Hospital using dorsaVi technology in their patient programs
ViMove is being used to validate patient outcomes in Pfizer supported study
[WEBINAR – WATCH NOW] Confidence in data: Sophie’s return to play story
Clinically acceptable agreement between the ViMove wireless motion sensor system and the Vicon motion capture system
dorsaVi wearable sensors follow race winner to the finish line
dorsaVi’s UK distributor signs retail pilot deal with Mizuno
dorsaVi launches US-based patient registry for low back pain to support reimbursement plans
How consistent are lordosis, range of movement and lumbo-pelvic rhythm in people with and without back pain?
Troy University First Collegiate Football Program To Test New Movement Analysis System
dorsaVi ViMove being used to identify Adolescent Idiopathic Scoliosis
Video: dorsaVi Training Day with RUN WITH SOLE Podcast Team
dorsaVi USA Market Update: Large OHS contracts, rapid clinical expansion and new sports team signings
College of Southern Idaho Men’s Basketball team using dorsaVi wearable sensor technology to gain a competitive edge
dorsaVi wearable sensors featured in Runner’s World
Wireless Technology Designed to Accurately, Objectively Measure and Analyze the Way we Move – An interview with Andrew Ronchi
A patient’s experience with ViMove and YourPhysioPlan
Debate over medical grade vs consumer wearables
Tech and Biotech – A match made in heaven
dorsaVi CEO Andrew Ronchi discusses the implications of consumer demand on technology and device adoption by medical firms
Motion analysis and the future of injury risk assessment
dorsaVi wearable sensors in extreme environments: From the desert to the icefields
dorsaVi featured on Beacon Orthopaedics Mind & Muscle Segment
“Can wearable technology “see” coming knee injuries before they happen?” dorsaVi featured at the PACE Prehab and Recovery clinic
Loren Landow harnesses technology to minimize his athlete’s injury risk
Australian Physiotherapy Association endorses dorsaVi wearable sensor technology
ViPerform Cameo appearance on ESPN. Thanks NY Sports Med!
Prehab not Rehab
Meet the ASX-listed Melbourne wearables startup that just scored some big US clients
Major US physical therapy provider adopts dorsaVi products across 20 clinics
Transform the way you run – a runner’s experience with ViMove
dorsaVi featured in Virgin Voyeur magazine for innovation
ViMove – putting the bio back into biopsychosocial rehabilitation
Lakers trainer searches for an injury solution
Three year agreement signed with UK physiotherapy network
dorsaVi signs New England Patriots (NFL) and two US Universities
Loren Landow, a renowned trainer, uses ViPerform technology on athletes, including Broncos
dorsaVi signs NFL teams to use ViPerform
dorsaVi’s US reimbursement strategy steps forward with CPT coding for ViMove and ViPerform
The effect of changing movement and posture using motion-sensor biofeedback, versus guidelines-based care, on the clinical outcomes of people with sub-acute or chronic low back pain – a multicentre, cluster-randomised, placebo-controlled, pilot trial
dorsaVi signs UK physiotherapy network
FDA approves ViMove for expanded use in the United States
Two NBA playoff contenders in the United States adopt ViPerform
São Paulo FC evaluate players with ViPerform during preseason training
Innovative partnership between dorsaVi and São Paulo FC
dorsaVi welcomes first US sale of ViPerform
dorsaVi signs first South American football team with ViPerform
dorsaVi to commence sale of ViMove in the US following FDA clearance
dorsaVi scores in international football market
dorsaVi expands into United States and New Zealand with ViMove
ViPerform adopted by seventh AFL Club
Elite sporting organisations adopting ViPerform
Show More